Cargando…

Validation of Biomarker-Based ABCD Score in Atrial Fibrillation Patients with a Non-Gender CHA(2)DS(2)-VASc Score 0–1: A Korean Multi-Center Cohort

PURPOSE: Atrial fibrillation (AF) patients with low to intermediate risk, defined as non-gender CHA(2)DS(2)-VASc score of 0–1, are still at risk of stroke. This study verified the usefulness of ABCD score [age (≥60 years), B-type natriuretic peptide (BNP) or N-terminal pro-BNP (≥300 pg/mL), creatini...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jung, Moonki, Byeon, Kyeongmin, Kang, Ki-Woon, Park, Yae Min, Hwang, You Mi, Lee, Sung Ho, Jin, Eun-Sun, Roh, Seung-Young, Kim, Jin Seok, Ahn, Jinhee, Lee, So-Ryoung, Choi, Eue-Keun, Ahn, Min-soo, Lee, Eun Mi, Park, Hwan-Cheol, Lee, Ki Hong, Kim, Min, Choi, Joon Hyouk, Ko, Jum Suk, Kim, Jin Bae, Kim, Changsoo, Lip, Gregory Y.H., Shin, Seung Yong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Yonsei University College of Medicine 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9520051/ https://www.ncbi.nlm.nih.gov/pubmed/36168241 http://dx.doi.org/10.3349/ymj.2022.0157

Ejemplares similares

CHA(2)DS(2)-VASc score predicts exercise intolerance in young and middle-aged male patients with asymptomatic atrial fibrillation
por: Yi, Jeong-Eun, et al.
Publicado: (2018)

Stroke and Systemic Thromboembolism according to CHA(2)DS(2)-VASc Score in Contemporary Korean Patients with Atrial Fibrillation
por: Lee, Kyung Bae, et al.
Publicado: (2022)

Net clinical benefit of oral anticoagulants in Korean atrial fibrillation patients with low to intermediate stroke risk: A report from the Clinical Survey on Stroke Prevention in patients with Atrial Fibrillation (CS‐SPAF)
por: Jung, Moonki, et al.
Publicado: (2023)

Predictors of stroke or systemic embolism in patients with non‐valvular atrial fibrillation with CHA(2)DS(2)‐VASc score of 0
por: Choi, Hyohun, et al.
Publicado: (2023)

CHA2DS2-VASc score in acute ischemic stroke with atrial fibrillation: results from the Clinical Research Collaboration for Stroke in Korea
por: Lee, Hak-Loh, et al.
Publicado: (2021)

Impact of carotid atherosclerosis in CHA(2)DS(2)-VASc-based risk score on predicting ischemic stroke in patients with atrial fibrillation
por: Cho, Dong-Hyuk, et al.
Publicado: (2021)

Cardiac Structural or Functional Changes Associated with CHA(2)DS(2)-VASc Scores in Nonvalvular Atrial Fibrillation: A Cross-Sectional Study Using Echocardiography
por: Jang, Albert Youngwoo, et al.
Publicado: (2018)

Predictors of stroke or systemic embolism in patients with non-valvular atrial fibrillation with CHA2DS2-VASc score of 0
por: Park, Y, et al.
Publicado: (2023)

CHADS(2), CHA(2)DS(2)-VASc, ATRIA, and Essen stroke risk scores in stroke with atrial fibrillation: A nationwide multicenter registry study
por: Yu, Inwu, et al.
Publicado: (2021)

CHA(2)DS(2)-Vasc score and CHA(2)DS(2)-Vasc-HS score are poor predictors of in-stent restenosis among patients with coronary drug-eluting stents
por: Zhao, Sheng Gang, et al.
Publicado: (2019)

CHA(2)DS(2)-VASc: time to settle the score?
por: Kaplan, Rachel M., et al.
Publicado: (2022)

Predicting stroke and death in patients with heart failure using CHA(2)DS(2)-VASc score in Asia
por: Son, Mi Kyoung, et al.
Publicado: (2019)

Association between CHADS(2), CHA(2)DS(2)-VASc, ATRIA, and Essen Stroke Risk Scores and Unsuccessful Recanalization after Endovascular Thrombectomy in Acute Ischemic Stroke Patients
por: Kim, Hyung Jun, et al.
Publicado: (2022)

CHA(2)DS(2)-VASc score, cerebral small vessel disease, and frailty in older patients with atrial fibrillation
por: Choi, Jung-Yeon, et al.
Publicado: (2020)

Association between CHADS(2), CHA(2)DS(2)-VASc, ATRIA, and Essen Stroke Risk Scores and Functional Outcomes in Acute Ischemic Stroke Patients Who Received Endovascular Thrombectomy
por: Kim, Hyung Jun, et al.
Publicado: (2022)

CHA(2)DS(2)-VASc Score in the Prediction of Ischemic Stroke in Patients after Radiofrequency Catheter Ablation of Typical Atrial Flutter
por: Jin, Moo-Nyun, et al.
Publicado: (2018)

CHA2DS2-VASc score and modified CHA2DS2-VASc score can predict mortality and intensive care unit hospitalization in COVID-19 patients
por: Gunduz, Ramazan, et al.
Publicado: (2021)

CHA(2)DS(2)-VASc Score in Cardio-Oncology: Sharpening the Rules
por: López-Fernández, Teresa
Publicado: (2023)

CHA2DS2-VASc Score for Major Adverse Cardiovascular Events Stratification in Patients with Pneumonia with and without Atrial Fibrillation
por: Wang, Bo-Yuan, et al.
Publicado: (2021)

Association between modified CHA(2)DS(2)-VASc Score with Ankle-Brachial index < 0.9
por: Hsu, Po-Chao, et al.
Publicado: (2018)

Better prediction of stroke in atrial fibrillation with incorporation of cancer in CHA(2)DS(2)VASC score: CCHA(2)DS(2)VASC score
por: Bungo, Brandon, et al.
Publicado: (2022)

CHA(2)DS(2)-VASc and R(2)-CHA(2)DS(2)-VASc scores predict in-hospital and post-discharge outcome in patients with myocardial infarction
por: Węgiel, Michał, et al.
Publicado: (2018)

Cheating the CHA(2)DS(2)-VASc Score: Thromboembolism in Apical Hypertrophic Cardiomyopathy
por: Weir, Robin A. P., et al.
Publicado: (2014)

Correlation between CHA(2)DS(2)-VASc Score and Glaucoma Treatment and Prognosis
por: Pikkel, Yoav Y., et al.
Publicado: (2018)

The association of CHA(2)DS(2)-VASc score and carotid plaque in patients with non-valvular atrial fibrillation
por: Shang, Luxiang, et al.
Publicado: (2019)

The Thromboembolic Predictability of CHA(2)DS(2)-VASc Scores Using Different Echocardiographic Criteria for Congestive Heart Failure in Korean Patients with Nonvalvular Atrial Fibrillation
por: Jang, Albert Youngwoo, et al.
Publicado: (2022)

Value of the CHA(2)DS(2)‐VASc score for predicting outcome in patients with heart failure
por: Shuvy, Mony, et al.
Publicado: (2020)

Coronary Embolism despite CHA₂DS₂-VASc Score of Zero: Should We Reconsider Anticoagulation?
por: Ahmed, Ammar, et al.
Publicado: (2021)

Does CHA2DS2-VASc score predict mortality in chronic kidney disease?
por: Goudis, Christos, et al.
Publicado: (2021)

Stroke and systemic embolism risk in patients with CHA(2)DS(2)‐VASc score of 0
por: Babayiğit, Erdi, et al.
Publicado: (2023)

Statin Therapy for Primary Prevention of Atrial Fibrillation: Guided by CHADS(2)/CHA(2)DS(2)VASc Score
por: Hung, Chen-Ying, et al.
Publicado: (2014)

Sex-Related Differences in Left Atrial Low-Voltage Areas According to CHA(2)DS(2)-VA Scores among Patients with Atrial Fibrillation
por: Kim, Do Young, et al.
Publicado: (2022)

Assessment of CHA(2)DS(2)-VASc score for predicting cardiovascular and cerebrovascular outcomes in acute myocardial infarction patients
por: Li, Chen-Yu, et al.
Publicado: (2018)

CHADS(2) and CHA(2)DS(2)-VASc Scoring Systems for Predicting Atrial Fibrillation following Cardiac Valve Surgery
por: Yin, Liang, et al.
Publicado: (2015)

Mortality Prediction of the CHA(2)DS(2)-VASc Score, the HAS-BLED Score, and Their Combination in Anticoagulated Patients with Atrial Fibrillation
por: Morrone, Doralisa, et al.
Publicado: (2020)

Using CHADS(2) and CHA(2)DS(2)-VASc scores for mortality prediction in patients with chronic kidney disease
por: Hsu, Po-Chao, et al.
Publicado: (2020)

CHA(2)DS(2)-VASc score as a prognostic indicator in patients with atrial fibrillation undergoing coronary stenting
por: ZHENG, Jian-Yong, et al.
Publicado: (2022)

High CHA(2)DS(2)-VASc score without atrial fibrillation: ‘NAO yes, NAO no’
por: Perna, Gian Piero
Publicado: (2019)

What should the C (‘congestive heart failure’) represent in the CHA(2)DS(2)‐VASc score?
por: Mulder, Bart A., et al.
Publicado: (2020)

CHA(2)DS(2)‐VASc Score and the Risk of Ventricular Tachyarrhythmic Events and Mortality in MADIT‐CRT
por: Nof, Eyal, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_bbgrja3s0uo7pe16s3g8inb4gt